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Abstract  Enterococci are leading causes of nosocomial bacteremia, surgical wound and urinary tract infections. 
They are ubiquitous bacteria commonly occurring in foods, and in recent years there has been increased attention 
towards multidrug strains incidence, since they may cause the failure of therapeutic treatments. Therefore, we 
analyzed the occurrence of Enterococcus species isolated from raw meat (beef, chicken and pork), cheese, and 
ready-to-eat salads, and the change of the antibiotic resistance in Enterococcus faecium and E. faecalis strains in a 
14 year survey. Among the 589 Enterococcus strains, E. faecium and E. faecalis represented the most numerous 
species in all types of food examined (42.8% and 38.7% respectively). Antibiotic resistance and number of Multi 
Drug Resistant strains have increased, reaching very high levels from 2002 to 2015. In the last two years, E. faecalis 
isolates sometimes reached percentages of resistance higher than 40% against tetracycline, vancomycin, linezolid, 
erythromycin, and ampicillin. Antibiotic resistance in E. faecium was lower than in E. faecalis for almost all 
antimicrobials tested. The highest percentage of resistance in 2014-2015 was registered for erythromycin (42.5%), 
followed by tetracycline (30%), ciprofloxacin, and linezolid (both 27.5%). The number of resistant phenotypes also 
increased during this survey in both species to more than 20 in 2014-2015. Despite the fact that Enterococcus spp. 
do not represent a problem for immunocompetent individuals, surveillance of antibiotic resistance in this kind of 
micro-organism continues to be important because, as shown in our results, antibiotic resistance has sharply 
increased in recent years. 
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1. Introduction 
Enterococci are ubiquitous bacteria commonly occurring 
in foods, especially those of animal origin, such as meat 
and milk [1], and those of soil origin [2,3]. Due to their 
primary habitat, identified in the gastrointestinal tract of 
animals, and due to contamination during slaughtering and 
manipulation, they can reach and hence contaminate water, 
environment, soil, and most foods. They are useful as 
fecal contaminant indicators owing to their ability to 
survive in very hostile environments [4]. They may also 
play a desirable role in the fermentation and ripening of 
certain foods of animal origin, such as cheese and fermented 
meat, because they are added during the production 
process of some foods, both to extend their shelf life and 
to improve their organoleptic properties and flavour [5,6]. 
As many authors reported, Enterococcus spp. are normally 
found in most foods, such as those of animal origin (raw 
meat, cheese) and vegetables, with predominance of E. faecalis 
and E. faecium [3,7-14], which are involved in severe 
human infections worldwide [15,16], especially in hospital 
acquired ones [17]. In recent years there has been increased 
attention towards multidrug strains incidence [18,19], since 
they may cause the failure of therapeutic treatment in case 
of enterococcal infections, especially in immunocompromised 
individuals, evolving into severe urinary tract diseases, 
bacteremias, and endocarditis [20], with E. faecalis bearing 
the principal responsibility for at least 70-80% of the cases 
[21]. Researchers suggested that Enterococci can be 
spread from animals and vegetables to man both through 
direct contact or through their consumption, leading to a 
spread of antibiotic resistance genes in human beings 
[22,23], furthermore they can transfer resistance genes to 
their own or other species [24,25,26,27], with the possibility 
of causing endogenous infections even in colonized humans 
[28]. The acquisition of resistance determinants can occur 
through gene transference by plasmids and transposons 
[29,30] and include aminoglycosides, chloramphenicol, β-
lactams, macrolides, quinolones, tetracycline, vancomycin 
and teicoplanin [31,32], as well as linezolid [18,33]. These 
new antibiotic resistances, together with the intrinsic ones 
to cephalosporins, and to low level aminoglycosides, 
polymixins, lincomycin, clindamycin, and often quinolones 
[34], can make the treatment of enterococcal infections 
very difficult. Antimicrobial resistant Enterococci are 
spread from hospitals to environment mostly through 
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water and feces, secondly, from humans and other sources, 
increasing their prevalence in environment, humans and 
animals, and becoming a potential risk for human health 
[13]. Since Enterococcus species show the same pattern as 
other bacteria in increasing their antibiotic resistance, 
especially nosocomial strains [18,19], we think that a 
continuous monitoring of antibiotic resistance in Enterococci 
is necessary, both for clinical and foodborne strains, to 
verify if any changes occur over the years. For this purpose, 
we analyzed the occurrence of Enterococcus species 
isolated from raw meat (beef, chicken and pork), cheese, 
and ready-to-eat salads (RTES), and the change of the 
antibiotic resistance in Enterococcus faecium and E. faecalis 
strains during this 14 year survey. 
2. Materials and Methods 
2.1. Bacterial Strains 
Enterococcus spp. were collected from Italian beef, poultry 
and pork, cheese, and RTES during a 14 year survey 
conducted in Italy from 2002 to 2015. Enterococci were 
isolated from food samples as previously described [35] in 
Slanetz and Bartley agar (Thermo Fisher Diagnostics, Milan, 
ITA) and incubated for 24±2 h at 37±1°C. Species identification 
was obtained through rapID STR (Thermo Fisher 
Diagnostics), according to the manufacturer’s instructions. 
2.2. Susceptibility Testing 
Antimicrobial susceptibility of the Enterococcus spp. 
strains were determined by the Kirby- Bauer disk 
diffusion method [36,37] on Mueller Hinton agar (Thermo 
Fisher Diagnostics). The plates were incubated at 35±1°C 
for 18±2h (for glycopeptides 24h) according to EUCAST 
disk diffusion method [37].  
Enterococcus faecalis ATCC 29212 and Enterococcus 
faecium ATCC 19434 were used as reference strains. 
Disks containing the following antibiotics (all from 
Thermo Fisher Diagnostics) were placed at 3 cm interval: 
amoxicillin/clavulanic acid - 30 µg (1:2), ampicillin  
- 2 µg, chloramphenicol - 30 µg, ciprofloxacin - 5 µg, 
erythromycin - 15 µg, linezolid - 10 µg, penicillin G - 10 
U.I., teicoplanin - 30 µg, tetracycline - 30 µg, vancomycin 
- 5 µg. Results were interpreted following EUCAST 
breakpoint tables [38] and, where not possible, according 
to CLSI [39] indications. 
2.2. Statistical Analysis 
The standard descriptive statistics of the contamination 
(percentages) and comparison tests were made using 
Stata/SE 8.0 (StataCorp, College Station, TX, USA). The 
frequencies were compared using the chi-squared test with 
a significant level of p-value < 0.05. 
3. Results and Discussion 
3.1. Prevalence of Enterococcus Species  
As many authors reported, among the 589 Enterococcus 
strains, E. faecium and E. faecalis represented the majority 
in all types of food examined (42.8% and 38.7% 
respectively), followed by E. durans (12.7%) and other 
species (Table 1). In particular, E. faecalis was more 
frequent in raw meat, while E. faecium was found more 
often in cheese and salads. 
Prevalence of Enterococcus species in beef was different 
from that found in the German study by Klein et al. [11], 
in which contamination was 89.8% E. faecalis, 2.8%  
E. gallinarum and E. durans and 1.8% E. faecium, and 
from the Hayes et al. [9] study in the U.S., in which 17.0% 
of beef was contaminated by E. faecalis, 65% by E. 
faecium and 14% by E. hirae. In poultry meat, E. faecalis 
was more frequent (44.7%) than E. faecium (30.7%) 
similarly to what Aarestrup et al. [40] found, but in contrast 
with other studies, such as Ali et al. [7], who reported  
17.2% and 66.2% respectively, or Kilonzo-Nthenge et al. 
[41], who did not isolate E. faecalis, but E. faecium 
(27.3%), E. gallinarum (6.0%), E. casseliflavus (2.1%), 
and E. durans (1.4%). Our samples of pig meat had high 
percentages of E. faecalis (45.0%) and E. faecium (41.6%), 
similar to the ones reported by Jahan et al. [10] and  
Li et al. [12] who isolated E. faecalis in percentages of 
51.7 and 36.9% and E. faecium of 44.8 and 53.6%, 
respectively. In several studies on cheese we observed 
highly variable percentages of Enterococcus species, 
probably due to the fact that these bacteria are part of the 
microflora of cheese. In Brazilian cheese [8], the most 
prevalent species were E. faecium (58.3%) and E. faecalis 
(27.8%), followed by E. casseliflavus (11.1%) and  
E. gallinarum (2.7%); in an Italian study [42] E. faecium 
was identified in 61.3% of the samples, percentage similar 
to what we detected, while E. faecalis was found only in 
6.66% in contrast to the 17.9% in this report. Our samples 
of mixed lettuce had high percentage of E. faecium 
(65.6%), according to Torre et al. [3] who detected  
59.1% of E. faecium, 18.1% of E. faecalis, 19% of  
E. durans and 3.8% of E. avium; E. faecalis was detected 
in 23.5% of the salad samples, similar to what reported  
by Ronconi et al. [2] who detected 32.6% of E. faecium, 
21.7% of E. faecalis followed by E. gallinarum (13.04%), 
E. casseliflavus and E. mundtii (7.60%), E. hirae, (6.52%) 
and E. durans (4.35%). 
Table 1. Number of positive samples and distribution of Enterococcus species in the products analyzed 
Species beef poultry pig cheese salads Total No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
E. faecium 46 (34.6) 46 (30.7) 62 (41.6) 75 (61.0) 23 (65.6) 252 (42.8) 
E. faecalis 64 (48.1) 67 (44.7) 67 (45.0) 22 (17.9) 8 (23.5) 228 (38.7) 
E. durans 15 (11.3) 23 (15.3) 14 (9.4) 22 (17.9) 1 (2.94) 75 (12.7) 
E. avium 8 (6.02) 8 (5.33) 5 (3.36) 4 (3.25) 0 25 (4.24) 
E. gallinarum 0 4 (2.67) 1 (0.67) 0 2 (5.88) 7 (1.19) 
E. raffinosus 0 1 (0.67) 0 0 0 1 (0.17) 
E. casseliflavus 0 1 (0.67) 0 0 0 1 (0.17) 
Total 133 150 149 123 34 589 
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All results, those cited and ours, are dissimilar (p<0.05), 
showing a not-regular distribution in time of Enterococcus 
species in animals and vegetables analyzed; this probably 
depends on environmental conditions in breeding and 
cultivation, including the quality of water used for 
watering animals and vegetables. 
3.2. Total Antibiotic Resistance on E. faecalis 
and E. faecium Strains 
Antibiotic resistance was determined only for E. faecium 
and E. faecalis strains, due to their importance in human 
infections. Of the 252 E. faecium identified, 13.1% were 
resistant to at least three antibiotics (Multi Drug Resistant, 
MDR), 28.6% were resistant to erythromycin, 17.9% to 
tetracycline, 12.7% to penicillin G and 12.3% to ciprofloxacin. 
Of the 228 E. faecalis identified, 23.7% were MDR,  
54.4% to tetracycline, 24.1% to erythromycin, 19.7% to 
vancomycin, 13.6% to linezolid, 10.5% to chloramphenicol, 
followed by other antimicrobials (Table 2). In E. faecalis a 
significantly higher prevalence of resistance to ampicillin, 
chloramphenicol, linezolid, tetracycline and vancomycin 
was detected than in E. faecium (p<0.05), while in  
E. faecium a greater prevalence of resistance to 
ciprofloxacin, erythromycin and penicillin G was found 
than in E. faecalis (p<0.05). Due to the fact that most of 
our strains were sensible to ampicillin and penicillin, we 
do not agree with the generalization that considers 
Enterococci intrinsically resistant to ß- lactams [34].  
Compared to our previous investigation [35], we detected 
higher resistance to all antimicrobials, particularly to 
vancomycin (Table 2), except for teicoplanin and 
tetracycline. Our results are in agreement with the general 
increment of multi resistant strains in recent years [43], 
infact percentages of E. faecium and E. faecalis isolates 
resistant to vancomycin were respectively 4.76% and 
19.7%, much higher than those reported in Europe by 
EFSA [43] in recent years. 
3.3. Antibiotic Resistance in the Types  
of Products Analyzed  
Enterococcal populations are different in animal species 
and vegetables, so we compared antibiotic resistance in  
E. faecium and E. faecalis in the different types of food 
examined (Table 2). 
Animals may acquire antibiotic resistant bacteria from 
the first moments of their life. Obeng et al. [44] concluded 
that, in chickens, a para-vertical transmission from egg shells 
to chicks could exist during hatching as a contamination 
through feeds. In fact, they found antibiotic resistant 
Enterococci from chicks of 3 days and older and, almost 
always, they observed an increasing trend of antibiotic resistance 
as chicks aged. In this study, carried out in Australia, 
Enterococci from chickens of 100 days were 53% resistant 
to ampicillin, 97% to erythromycin, and 100% to tetracycline. 
Amaechi and Nwankwo [45] found percentages of antibiotic 
resistance in Enterococci from poultry higher than ours 
(Table 3): 21.8% to ciprofloxacin, 71.2% to erythromycin, 
and 76.7% to chloramphenicol. Very different antibiotic 
resistance percentages are probably due to different 
selections of bacteria caused by different legislation in 
various countries regarding the use of nontherapeutic 
antimicrobial growth promoters in animal feed [22,44,45]. 
As most authors reported [22,44,46], erythromycin  
and tetracycline resistance were highly distributed in  
E. faecium and E. faecalis, although in different 
percentages. The highest resistance levels among E. 
faecium and E. faecalis isolates were from poultry and 
were comparable to European data [43]. 
Table 2. Number and percentage of antibiotic resistance among all E. faecium and E. faecalis strains in the types of products analyzed 














Amox/Clavul. 1 (0.85) 2 (1.41) 4 (2.84) 0 0 7 (1.24) 
Ampicillin 14 (11.9) 6 (4.20) 19 (13.5) 6 (4.92) 0 49 (8.70) 
Chloramphenicol 13 (11.0) 7 (4.90) 13 (9.22) 6 (4.92) 0 39 (6.91) 
Ciprofloxacin 6 (5.08) 6 (4.20) 19 (13.5) 13 (10.7) 5 (14.7) 49 (8.69) 
Erythromycin 14 (11.9) 26 (18.2) 76 (53.9) 28 (22.9) 3 (8.82) 148(26.2) 
Linezolid 3 (2.54) 8 (5.60) 24 (17.0) 12 (9.84) 3 (8.82) 50 (8.87) 
Penicillin G 3 (2.54) 6 (4.20) 26 (18.4) 8 (6.56) 3 (8.82) 46 (8.16) 
Teicoplanin 1 (0.85) 3 (2.10) 2 (1.42) 6 (4.92) 0 12 (2.13) 
Tetracycline 38 (32.2) 45 (31.5) 102(72.3) 5 (4.10) 5 (14.7) 198 (35.1) 
Vancomycin 15 (12.7) 8 (5.60) 25 (17.7) 12 (9.84) 1 (2.94) 63 (11.2) 
 Enterococcus faecium No. (%) Enterococcus faecalis No. (%) 
 beef pig poultry cheese salads Total beef pig poultry cheese salads Total 
Amox/Clavul. 0 0 2 (4.35) 0 0 2 (0.79) 0 2 (2.99) 0 0 0 2 (0.88) 
Ampicillin 4 (8.70) 0 9 (19.6) 2 (2.67) 0 15 (5.95) 13 (20.3) 4 (5.97) 6 (9.0) 4 (18.2) 0 27 (11.8) 
Chloramphenicol 2 (4.35) 3 (4.84) 4 (8.70) 3 (4.00) 0 12 (4.76) 10 (15.6) 3 (4.48) 8 (11.9) 3 (13.6) 0 24 (10.5) 
Ciprofloxacin 3 (6.52) 3 (4.84) 12 (26.1) 11 (14.7) 2 (8.70) 31 (12.3) 2 (3.13) 3 (4.48) 4 (6.00) 0 2 (25.0) 11 (4.82) 
Erythromycin 6 (13.0) 13 (21.0) 27 (58.7) 23 (30.7) 3 (13.0) 72 (28.6) 8 (12.5) 10 (14.9) 34 (50.7) 3 (13.6) 0 55 (24.1) 
Linezolid 0 0 5 (10.9) 8 (10.7) 1 (4.35) 14 (5.56) 2 (3.13) 8 (11.9) 16 (23.9) 3 (13.6) 2 (25.0) 31 (13.6) 
Penicillin G 2 (4.35) 3 (4.84) 17 (37.0) 7 (9.33) 3 (13.0) 32 (12.7) 1 (1.56) 1 (1.49) 2 (3.00) 0 0 4 (1.75) 
Teicoplanin 1 (2.17) 3 (4.84) 1 (2.17) 2 (2.67) 0 7 (2.78) 0 0 1 (1.49) 2 (9.09) 0 3 (1.32) 
Tetracycline 6 (13.0) 9 (14.5) 27 (58.7) 2 (2.67) 1 (4.15) 45 (17.9) 32 (50.0) 31 (46.3) 55 (82.1) 2 (9.09) 4 (50.0) 124 (54.4) 
Vancomycin 3 (6.52) 2 (3.23) 2 (4.35) 4 (5.33) 1 (4.35) 12 (4.76) 13 (20.3) 6 (8.96) 21 (31.3) 5 (22.7) 0 45 (19.7) 
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The percentages of antibiotic resistance in Enterococci 
from pigs isolated by Amaechi and Nwankwo [45] in 
Nigeria were 21.7% to ciprofloxacin, 71.8% to erythromycin 
and 85.8% to chloramphenicol. Our percentages were 
much lower, even compared to some antimicrobials cited 
in EFSA Summary Report [43], such as chloramphenicol, 
erythromycin and tetracycline for E. faecalis and 
ampicillin, erythromycin, linezolid and tetracycline for  
E. faecium.  
Beef samples were contaminated by Enterococci  
mostly resistant to tetracycline, ampicillin, vancomycin, 
erythromycin and chloramphenicol, although with lower 
levels compared to those of EFSA [47], which reported 
absence of resistance to vancomycin in Spain, whereas we 
found resistance both in E. faecalis and E. faecium isolates.  
In cheese, we observed a higher prevalence (p<0.05)  
of resistant E. faecalis than E. faecium (Table 2) for 
ampicillin, chloramphenicol, linezolid, teicoplanin, tetracycline, 
and vancomycin, with percentages similar to those 
observed by Furlaneto-Maia et al. [8]. 
Despite the low number of strains isolated in salads 
compared to our previous investigation [35], we did  
note an increase in resistance against linezolid, one  
of the first-line therapeutic options for the treatment of 
vancomycin-resistant Enterococci (VRE) infections. 
Ciprofloxacin and erythromycin resistance was spread 
in many E. faecium isolates from all analyzed types of 
food, whereas chloramphenicol, erythromycin, and 
tetracycline resistance was present in E. faecalis isolates 
from all the food groups, with the exception of salads.  
3.4. Antibiotic Resistance Survey 
To date, Enterococci are considered one of the most 
important opportunistic pathogens due to the high number 
of infections they cause, especially in immunocompromized 
patients, with severe underlying diseases [8]. The increasing 
levels of acquired resistance to antimicrobials is of special 
concern in public health because the therapeutic options 
are becoming ever more limited [48]. Furthermore, the 
transferring of antibiotic resistance genes through 
plasmids and transposons could occur between bacteria 
belonging to the same or different genus and in the 
intestinal tract of humans and animals [24]. Therefore the 
food chain is now considered one of the main routes of 
transmission of bacteria containing antimicrobial 
resistance genes between animals and humans [49]. With 
this in mind, we observed the variation of susceptibility of 
either E. faecalis or E. faecium over the years. Our results 
showed lower or similar resistance levels compared to 
other countries, mainly Austria and Switzerland [43]. As 
shown in Figure 1 and Figure 2, antibiotic resistance 
increased for almost all antimicrobials reaching very high 
levels from 2002 to 2015. 
E. faecalis isolates in the last biennium reached 
percentages of resistance against tetracycline and 
vancomycin of 69.2% and 59.6%, respectively. Lower 
percentages were seen for linezolid (44.2%) erythromycin  
and ampicillin (both 40.4%). 
Sensitivity to glycopeptides was different: we observed 
high sensitivity to teicoplanin, while vancomycin-resistant 
strains sharply increased in the past four years. Resistance 
to linezolid has always been low, but nearly doubled  
in the last two years, reaching worrisome percentages. 
Sensitivity to erythromycin and tetracycline also decreased, 
causing a reduction in efficacy of these antibiotics. We did 
not observe many strains resistant to chloramphenicol as 
the percentages were always lower than 26%. 
 
Figure 1. Temporal trends (2002-2015) in resistance among E. faecalis. 
Tet, tetracycline; Ery, erythromycin; C, chloramphenicol; Cip, 
ciprofloxacin; Pen G, penicillin G; Amp, ampicillin; Tei, teicoplanin; 
Van, vancomycin; Amox/cla, amoxicillin/clavulanic acid; Lis, linezolid 
 
Figure 2. Temporal trends (2002-2015) in resistance among E. faecium. 
Tet, tetracycline; Ery, erythromycin; C, chloramphenicol; Cip, 
ciprofloxacin; Pen G, penicillin G; Amp, ampicillin; Tei, teicoplanin; 
Van, vancomycin; Amox/cla, amoxicillin/clavulanic acid; Lis, linezolid 
Antibiotic resistance in E. faecium was lower than in E. 
faecalis for almost all antimicrobials: the highest 
percentage of resistance in 2014-2015 was seen for 
erythromycin (42.5%), followed by tetracycline (30%), 
ciprofloxacin, and linezolid (both 27.5%). We observed 
peaks of resistance occurring to almost all antibiotics in 
2006-07. In contrast to the data shown in the EFSA report 
[43] for some countries, a general increase of resistance 
was also observed for E. faecium, especially in the last 
four years, with a more noticeable increase for some 
antimicrobials such as ciprofloxacin, erythromycin, 
tetracycline and linezolid.  
In beef, we isolated E. faecalis resistant to tetracycline 
(Table 4) in all the years of sampling with a dramatic 
increase in the last two years, while penicillin G, 
teicoplanin, and amoxicillin/clavulanic acid resistance 
were not observed. Linezolid resistance was only observed 
in the last biennium, and vancomycin resistance has been 
fluctuating, as documented in human infections [50,51]. 
According to general results, resistance in E. faecium 
(Table 5) was lower than in E. faecalis: from 2006 
onwards, tetracycline was ineffective on 10%-33.3% of 
strains. Vancomycin resistance was observed only in 
2006-2007 and in the last biennium. 
Poultry showed the constant presence of E. faecalis 
resistant to erythromycin and tetracycline from 2004 
onwards at fluctuating rates, as in other European 
countries [43]. Rates of E. faecium resistant to penicillin G, 
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tetracycline and erythromycin were similar to France and 
Austria. Resistance of E. faecium strains to other 
antibiotics occurred more frequently in the last two years, 
and particularly to linezolid, vancomycin and ampicillin. 
In pork, we observed an increase of resistance in the 
last two biennia in E. faecium against most of the 
antimicrobials, except for ampicillin, ciprofloxacin, 
linezolid, and amoxicillin/clavulanic acid, which remained 
active against this bacteria with a sensitivity rate of 100% 
from 2010 onwards. E. faecalis resistance increased 
against ampicillin and decreased against vancomycin 
(from 75% to 42.9%), amoxicillin/clavulanic acid (from 
25% to 14.3%) and linezolid (from 75% to 71.4%). 
Resistance patterns of cheese strains varied over the 
years for both E. faecalis and E. faecium. The high percentages 
of vancomycin resistant E. faecalis and linezolid resistant 
E. faecium are alarming, confirming the necessity to use 
starter strains with antibiotic controlled resistance [5,52]. 
Table 4. Antibiotic resistance percentages in E. faecalis strains 













Beef        
Amox/cla 11.1 0 0 0 0 0 0 
Amp 11.1 7.69 14.3 0 0 14.3 69.2 
C 11.1 15.4 42.9 10.0 25.0 0 15.4 
Cip 0 0 14.3 0 0 0 7.69 
Ery 11.1 7.69 14.3 30.0 0 0 23.1 
Lis 0 0 0 0 0 0 15.4 
PenG 22.2 0 0 0 0 0 0 
Tei 0 0 0 0 0 0 0 
Tet 44.4 53.8 42.9 40.0 50.0 14.3 84.6 
Van 0 0 42.9 0 0 57.1 38.5 
Poultry        
Amox/cla n.d. 0 0 0 0 0 0 
Amp n.d. 0 0 0 0 0 26.1 
C n.d. 0 22.2 0 42.9 16.7 8.70 
Cip n.d. 0 11.1 0 0 0 13.0 
Ery n.d. 13.3 55.6 50.0 71.4 50.0 69.6 
Lis n.d. 6.67 0 0 0 33.3 56.5 
PenG n.d. 0 22.2 0 0 0 0 
Tei n.d. 0 11.1 0 0 0 0 
Tet n.d. 86.7 77.8 83.3 57.1 66.7 91.3 
Van n.d. 0 11.1 0 0 16.7 82.6 
Pig        
Amox/cla 0 0 0 0 0 25.0 14.3 
Amp 0 0 0 0 0 25.0 42.9 
C 0 0 0 13.3 8.33 0 0 
Cip 0 10.0 7.14 0 8.33 0 0 
Ery 0 10.0 21.4 20.0 8.33 0 28.6 
Lis 0 0 0 0 0 75.0 71.4 
PenG 0 0 0 6.67 0 0 0 
Tei 0 0 0 0 0 0 0 
Tet 40.0 40.0 78.6 66.7 25.0 0 14.3 
Van 0 0 0 0 0 75.0 42.9 
Cheese        
Amox/cla n.d. 0 0 n.d. 0 0 0 
Amp n.d. 0 0 n.d. 25.0 0 33.3 
C n.d. 25.0 0 n.d. 50.0 0 0 
Cip n.d. 0 0 n.d. 0 0 0 
Ery n.d. 25.0 0 n.d. 25.0 0 0 
Lis n.d. 0 0 n.d. 0 33.3 33.3 
PenG n.d. 0 0 n.d. 0 0 0 
Tei n.d. 0 0 n.d. 25.0 0 0 
Tet n.d. 25.0 33.3 n.d. 0 0 0 
Van n.d. 0 0 n.d. 25.0 0 66.7 
n.d. not determined (number of strains <5); Amp, ampicillin; Pen G, penicillin G; Tet, tetracycline; Ery, erythromycin; Van, vancomycin; Tei, 
teicoplanin; C, chloramphenicol; Cip, ciprofloxacin; Lis, linezolid; Amox/cla, amoxicillin/clavulanic acid. 
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Due to the limited number of strains isolated from 
RTES, we could study antibiotic resistance trend just for  
E. faecium. Since ready-to-eat salads are not rewashed or 
cooked before their consumption, a positive note is that 
we found few contaminating strains, like McGowan et al. 
[53], and they did not present much antibiotic resistance. 
Table 5. Antibiotic resistance percentages in E. faecium strains 













Beef        
Amox/cla 0 0 0 0 0 n.d. 0 
Amp 0 0 10.0 0 0 n.d. 50.0 
C 0 11.1 10.0 0 0 n.d. 0 
Cip 0 0 20.0 11.1 0 n.d. 0 
Ery 0 11.1 20.0 11.1 0 n.d. 16.7 
Lis 0 0 0 0 0 n.d. 0 
PenG 0 0 20.0 0 0 n.d. 0 
Tei 0 0 10.0 0 0 n.d. 0 
Tet 0 0 10.0 33.3 16.7 n.d. 16.7 
Van 0 0 20.0 0 0 n.d. 16.7 
Poultry        
Amox/cla n.d. 0 0 0 0 n.d. 0 
Amp n.d. 0 14.3 0 0 n.d. 38.5 
C n.d. 11.1 28.6 11.1 0 n.d. 7.69 
Cip n.d. 0 14.3 0 16.7 n.d. 53.8 
Ery n.d. 44.4 85.7 44.4 33.3 n.d. 76.9 
Lis n.d. 11.1 0 11.1 0 n.d. 30.8 
PenG n.d. 22.2 14.3 22.2 66.7 n.d. 38.5 
Tei n.d. 0 0 0 0 n.d. 0 
Tet n.d. 55.6 71.4 55.6 33.3 n.d. 53.8 
Van n.d. 0 0 0 0 n.d. 15.4 
Pig        
Amox/cla 0 0 0 0 0 0 0 
Amp 0 0 0 0 0 0 0 
C 0 0 0 0 0 25.0 40.0 
Cip 0 6.67 14.3 4.55 0 0 0 
Ery 0 0 14.3 22.7 66.7 25.0 80.0 
Lis 0 0 0 0 0 0 0 
PenG 0 0 0 4.55 0 0 40.0 
Tei 0 0 0 0 0 25.0 40.0 
Tet 0 0 0 9.09 0 75.0 80.0 
Van 0 0 0 0 0 25.0 20.0 
Cheese        
Amox/cla n.d. 0 0 0 0 0 0 
Amp n.d. 0 8.33 0 0 14.3 0 
C n.d. 6.67 8.33 0 0 14.3 0 
Cip n.d. 20.0 25.0 0 15.4 0 28.6 
Ery n.d. 6.67 33.3 52.6 38.5 28.6 14.3 
Lis n.d. 0 0 0 0 28.6 71.4 
PenG n.d. 0 33.3 0 7.69 28.6 0 
Tei n.d. 0 16.7 0 0 0 0 
Tet n.d. 0 0 0 15.4 0 0 
Van n.d. 0 16.7 0 0 28.6 0 
Ready Salads        
Amox/cla n.d. 0 0 0 n.d. n.d. 0 
Amp n.d. 0 0 0 n.d. n.d. 0 
C n.d. 0 0 0 n.d. n.d. 0 
Cip n.d. 20.0 0 0 n.d. n.d. 0 
Ery n.d. 20.0 0 20.0 n.d. n.d. 16.7 
Lis n.d. 0 0 0 n.d. n.d. 0 
PenG n.d. 0 20.0 20.0 n.d. n.d. 16.7 
Tei n.d. 0 0 0 n.d. n.d. 0 
Tet n.d. 20.0 0 0 n.d. n.d. 0 
Van n.d. 20.0 0 0 n.d. n.d. 0 
n.d. not determined (number of strains <5); Amp, ampicillin; Pen G, penicillin G; Tet, tetracycline; Ery, erythromycin; Van, vancomycin; Tei, 
teicoplanin; C, chloramphenicol; Cip, ciprofloxacin; Lis, linezolid; Amox/cla, amoxicillin/clavulanic acid. 
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From data presented in Table 4 and Table 5 and Figure 1 
and Figure 2, we point out that in the first four years of the 
survey we did not isolate any VRE, except for one strain 
identified in 2004-2005 in RTES. From 2006 onwards, 
vancomycin resistance was observed in beef, poultry and 
cheese, and then in pig, with the highest percentages 
appearing in the last four years. The absence of VRE in 
the first years of the survey was probably due to the 
abolition of avoparcin (1997) as an antibiotic and growth 
promoter used in veterinary medicine [35], leading to an 
inferior spreading of these strains through the food chain, 
but most probably due to the limited use of this antibiotic 
as feed additive in Italy since, once acquired, antibiotic 
resistance traits tend to persist [54]. It might be possible 
that clinical strains of VRE are spreading in community 
and environment [13] because it has been demonstrated 
that glycopeptide-resistant Enterococci isolated from meat 
products (chicken and pork) are able to overcome the 
gastric barrier and actively multiply in the human intestine 
[55]. In 2013, in Europe [43], vancomycin resistant  
E. faecium and E. faecalis had percentages lower than 2% 
from all types of food samples, whereas in this study we 
found much higher percentages of VRE. Moreover, 
vancomycin-resistant E. faecalis in the 2014-15 biennium 
have increased dramatically, considering that the mean in 
all foods analyzed was about 60%, according to the  
results found by Guerrero-Ramos et al. [56]. The most 
vancomycin resistant E. faecalis were the ones isolated 
from poultry in the last biennium (82.6%). 
Enterococci also showed a worrisome decreased 
sensitivity against linezolid: in the last two biennia  
E. faecalis reached resistance percentages of 71.4% in pig, 
56.5% in poultry and 33.3% in cheese, whereas E. faecium 
of 71.4% in cheese and 30.8% in poultry. 
Citak et al. [57] reported Enterococci resistant to penicillin, 
tetracycline, chloramphenicol, erythromycin, teicoplanin 
and vancomycin until 2005. Over the years, our strains also 
became resistant to ampicillin, ciprofloxacin and linezolid. 
Despite EU Regulation No. 1831/2003 [58] on additives 
for use in animal nutrition, which stated that antibiotics 
could only be used when prescribed and not as growth 
promoters, we did not observe a decrease in resistance 
prevalence, in particular for erythromycin and tetracyclines, 
widely used worldwide as feed additives [59]. 
Overuse and misuse of antibiotics are largely regarded 
as main factors in promoting antibiotic resistance. As 
previously noted, Enterococci are intrinsically resistant to 
many commonly used antimicrobial agents and they have 
the ability to rapidly express resistance genes in response 
to selective pressure [55]. For this reason, environmental 
Enterococci are a source of antimicrobial resistance genes 
and they have an important role in the gene exchange 
between clinical and environmental bacteria [60]. 
The increase of resistant Enterococci could be explained 
by the overuse of antibiotics in agriculture and livestock 
facilities, as reported in many studies [61,62,63,64]. Antibiotics 
used on farms, especially if administered in high doses or 
if added to the feed in sublethal concentrations, can reach 
the surrounding environment through animal excrements, 
water run-off and sewage. Consequently, the natural 
environment becomes a reservoir of antibiotic residues 
that enhances the spread of resistance genes in microbial 
communities [65]. This condition is supported by the 
persistence of particular antibiotic-resistant clones non-
sensitive to banning interventions, as previously reported 
[61,66]. Moreover, resistant Enterococci can spread among 
different geographical areas through importation and 
exportation of livestocks. This is the reason why it would 
be desirable the transport of already slaughtered animals. 
Although in the European Union antibiotics cannot be 
used for growth promotion and a veterinary prescription is 
always required, most countries, including Italy, still 
permit antibiotics to be used for routine disease prevention. 
In 2015 farm antibiotic use in Italy was well above the EU 
average, with a weight of active ingredient per unit of 
livestock of 322.0 mg/PCU, whereas the average for 25 
European countries was 141 mg/PCU [67]. 
Resistant Enterococci can enter humans for example 
through direct contact between humans and animals or 
through transmission via food (ingestion of contaminated 
raw foods of animal and vegetal origin, consumption of 
crops grown by contaminated sludge used as fertilizer, 
drinking of water drawn from contaminated ground or 
surface water). Some studies showed that the same 
resistance gene are found in bacteria isolated from both 
food samples and patients [31,68], supporting the 
hypothesis that Enterococci from food have the capacity to 
spread their resistance genes to the human microbiome 
and to disseminate in the bacterial community [65,69]. 
Finally, another reason that could explain the emergence 
of resistant Enterococci would be the massive use of 
antibiotic in clinical contexts. Enterococci, as normal 
commensals of the human gastrointestinal tract, are 
exposed to antibiotics during medical treatment. Resistant 
Enterococci can colonize the gut, deplete the protective 
commensals (Lactobacillus spp. and Bifidobacterium spp.) 
and spread from patient to patient within the hospital 
setting [69]. In support of our results, it is interesting to 
note that Italy have one of the highest levels of antibiotic 
consumption for systemic use in the EU, i.e. about 30 
defined daily doses per 1000 inhabitants per day [70]. 
3.5. Antibiotic Resistance Phenotypes 
We observed that both E. faecium and E. faecalis multi 
drug resistance had fluctuating rates in the first years of 
the survey, reaching 20% in 2006-2007, and increasing 
from 2009 onwards (Figure 3).  
The number of resistance phenotypes also increased 
during this survey in E. faecium and in E. faecalis from 1 and 
3 in 2002-2003, to 20 and 24 in 2014-2015, respectively.  
 
Figure 3. Time line of number of phenotypes (histograms) and MDR 
(lines) of E. faecalis (grey) and E. faecium (black) 
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Some antibiotic resistances, such as to tetracycline and 
tetracycline together with erythromycin, were present 
constantly over the years in both species, and particularly 
in E. faecalis (Table 6 and Table 7). Percentages of E. 
faecalis strains resistant only to tetracycline and of E. 
faecium strains resistant only to erythromycin were higher 
than those of erythromycin together with tetracycline, as 
Hidano et al. [71] observed.  
Our results are not in agreement with the findings of  
De Leener et al. [72] in which trasposons Tn 1545 are 
more frequent in Enterococci from pork than from other 
foods. In our study, we observed higher resistance against 
tetracycline together with erythromycin in poultry (53.2%), 
probably due to the extended use of these antibiotics as 
growth promoters until 1973 [59]. No statistical difference 
was found between the prevalence of coupled tetracycline 
and erythromycin resistance in E. faecium and E. faecalis 
strains in the types of food analyzed. The fluctuating 
presence of resistant E. faecalis to both vancomycin and 
linezolid and of resistant E. faecium to linezolid is worrisome. 
Table 6. Percentages of antibiotic resistance phenotypes of E. faecalis 
E. faecalis 2002-03 2004-05 2006-07 2008-09 2010-11 2012-13 2014-15 Total 
Amp       1.92 0.65 
Amp+Tet       3.85 1.29 
Amp+Tet+Ery       1.92 0.65 
Amp+Tet+Ery+Van       3.85 1.29 
Amp+Tet+Ery+Van+Lis       1.92 0.65 
Amp+Tet+Ery+Clor       1.92 0.65 
Amp+Tet+Van       3.85 1.29 
Amp+Tet+Van+Lis       1.92 0.65 
Amp+Tet+Van+Clor+Cip       1.92 0.65 
Amp+Van+Clor   3.03     0.65 
Amp+C  2.33      0.65 
Amp+Ery+Lis      4.76 3.85 1.94 
Amp+Ery+Van       1.92 0.65 
Amp+Van     3.70 4.76  1.29 
Amp+Van+Lis       3.85 1.29 
Amp+Lis+Amox/Cla      4.76  0.65 
Amp+Lis       1.92 0.65 
PenG    2.63    0.65 
PenG+Tet 4.76       0.65 
PenG+Tet+Ery+Van+Tei+C+Cip   3.03     0.65 
PenG+Tet+Ery   3.03     0.65 
Tet 23.81 46.5 39.4 31.6 14.8 9.52 7.69 38.7 
Tet+Ery+Cip  2.33 3.03     1.29 
Tet+Ery+C  4.65 3.03 5.26 11.1 4.76 1.92 6.45 
Tet+Ery  4.65 12.1 15.8 3.70 4.76  9.03 
Tet+Ery+C+Cip     3.70   0.65 
Tet+Ery+Van       5.77 1.94 
Tet+Ery+Van+Liz       9.62 3.23 
Tet+Ery+Van+Clor+Cip+Lis       1.92 0.65 
Tet+Ery+Van+Cip+Lis       3.85 1.29 
Tet+Van   3.03     0.65 
Tet+Lis       1.92 0.65 
Tet+Van+Lis      4.76 1.92 1.29 
Tet+Cip+Lis      4.76 1.92 1.29 
Ery+Van+C+Cip   3.03     0.65 
Ery+C    2.63    0.65 
Ery     3.70 4.76  1.29 
Ery+Tei+Clor     3.70   0.65 
C 4.76  3.03  7.41   2.58 
Lis  2.33    4.76  1.29 
Van      23.8 1.92 3.87 
van+Lis      9.52 5.77 3.23 
Tei      4.76  0.65 
Amp, ampicillin; Pen G, penicillin G; Tet, tetracycline; Ery, erythromycin; Van, vancomycin; Tei, teicoplanin; C, chloramphenicol; Cip, ciprofloxacin; 
Lis, linezolid; Amox/cla, amoxicillin/clavulanic acid. 
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Table 7. Percentages of antibiotic resistance phenotypes of E. faecium 
E. faecium 2002-03 2004-05 2006-07 2008-09 2010-11 2012-13 2014-15 Total 
Amp       2.50 0.85 
Amp+Tet       2.50 0.85 
Amp+PenG   2.38     0.85 
Amp+PenG+Van+Cip   2.38     0.85 
Amp+Pen+Tet+Ery+Cip+Amox/Cla      7.14  0.85 
Amp+Pen+Tet+Ery+Cip       5.00 1.71 
Amp+Pen+Tet+Ery+Lis       2.50 0.85 
Amp+Pen+Tet+Ery+Amox/Cla 9.09       0.85 
Amp+Pen+Tet  1.85      0.85 
Amp+Pen+Ery      7.14  0.85 
Amp+Pen+Tet+Ery   2.38     0.85 
Amp+Pen+Cip+Lis       2.50 0.85 
Amp+Ery+Cip       2.50 0.85 
Amp+Ery       2.50 0.85 
Pen   2.38 1.54 3.33  2.50 3.42 
Pen+Tet    1.54    0.85 
Pen+Tet+Ery  1.85  1.54 3.33  2.50 3.42 
Pen+Ery   4.76  6.67   3.42 
Pen+Ery+Van+Tei+C+Cip   2.38     0.85 
Pen+Ery+Van+Cip   2.38     0.85 
Pen+Ery+Cip       2.50 0.85 
Pen+Ery+Lis      7.14  0.85 
Pen+Tet+Cip  1.85   3.33   1.71 
Pen+Tet+Lis    1.54    0.85 
Tet    6.15 6.67 7.14  5.98 
Tet+Ery  5.56 4.76 1.54   2.50 5.98 
Tet+Cip  1.85   3.33  2.50 2.56 
Tet+Ery+C   2.38 1.54    1.71 
Tet+Van+Tei+C+Cip   2.38     0.85 
Tet+Ery+C+Cip   2.38     0.85 
Tet+Ery+Tei+C      7.14 5.00 2.56 
Tet+Ery+Van+C       2.50 0.85 
Tet+Ery+Van+Cip+Lis       2.50 0.85 
Tet+Ery+Cip    1.54    0.85 
Ery  3.70 9.52 26.1 20.0 7.14 5.00 27.3 
Ery+Lis       5.00 1.71 
Van      7.14 2.50 1.71 
Van+Cip  1.85      0.85 
Tei  1.85 2.38     1.71 
C+Cip  1.85      0.85 
C  1.85    7.14  1.71 
Cip  5.56 2.38 1.54 3.33   5.13 
Lis      7.14 5.00 2.56 
Cip+Lis       10.0 3.42 
Amp, ampicillin; Pen G, penicillin G; Tet, tetracycline; Ery, erythromycin; Van, vancomycin; Tei, teicoplanin; C, chloramphenicol; Cip, ciprofloxacin; 
Lis, linezolid; Amox/cla, amoxicillin/clavulanic acid. 
 
4. Conclusions 
Over the past few decades, Enterococci have become 
one of our most challenging nosocomial problems. They 
can survive and live in adverse environmental conditions, 
and have therefore the ability to colonize different 
ecological niches and spread within the food chain 
through contaminated animals and foods.  
Our study focused on Enterococcus strains collected 
from 2002 to 2015 and showed an increase of antibiotic 
resistance for almost all antimicrobials, especially tetracycline 
and vancomycin in E. faecalis and erythromycin, tetracycline, 
ciprofloxacin and linezolid in E. faecium. We suppose that 
the trend observed has not changed in the biennium 2016-
2017, in particular because Italy has taken limited actions 
so far aimed at reducing farm antibiotic use and resistance.  
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Despite the fact that many Enterococci with one or 
more antibiotic resistances have been noted, we can 
conclude that the use of some antibiotics, such as ß-lactam, 
may be effective in most cases. As happens in many 
therapies for the treatment of enterococcal infections, the 
combined use of antibiotic molecules belonging to 
different classes can often be very useful, as well as the 
use of more recently discovered drugs, such as linezolid, 
to which 91.1% of the tested strains were sensitive. 
Finally, although Enterococcus spp. do not represent a 
problem for immunocompetent individuals, there is a need 
to monitor their presence and reduce their opportunity to 
spread because, as shown by our results, antibiotic-
resistance has sharply increased in recent years. It would 
be useful to identify new effective antibiotics for the 
treatment of enterococcal infections and to try to reduce 
the diffusion of resistant Enterococci, limiting or avoiding 
the use of strains which present specific antibiotic 
resistance genes in food production and as probiotics. 
Furthermore, it’s important to focus on reducing 
antibiotic use, improving surveillance and better 
understanding the interaction between enterococci, the 
hospital environment, and humans. Good hand hygiene 
and proper cleaning are also essential for patients to 
minimize the spread of enterococci in the clinical settings. 
References 
[1] Giraffa, G., “Enterococci from foods”, FEMS Microbiol. Rev. 
2002, 26:163-171. 
[2] Ronconi, M.C., Merino, L.A. and Fernández, G., “Detection of 
Enterococcus with high-level aminoglycoside and glycopeptide 
resistance in Lactuca sativa (lettuce)”, Enferm. Infecc. Microbiol. 
Clin. 2002, 20:380-383. 
[3] Torre, I., Pennino, F., Diana, M.V., De Marco, G., Trotta, A.M., 
Borriello, T. and Troiano, E., “Antimicrobial susceptibility and 
glycopeptide-resistance of enterococci in vegetables”, Ital. J. 
Public Health. 2010, 7:47-53. 
[4] Wheeler, A.L., Hartel, P.G, Godfrey, D.G, Hill, J.L., and Segars, 
W.I., “Potential of Enterococcus faecalis as a human fecal 
indicator for microbial source tracking”, J. Environ. Qual. 2002, 
31:1286-1293. 
[5] Cocolin, L., Foschino, R., Comi, G. and Fortina, M.G., 
“Description of the bacteriocins produced by two strains of 
Enterococcus faecium isolated from Italian goat milk”, Food 
Microbiol. 2007, 24:752-758. 
[6] Foulquié Moreno, M.R, Sarantinopoulos, P., Tsakalidou, E. and 
De Vuyst, L., “The role and application of Enterococci in food and 
health”, Int. J. Food Microbiol. 2006, 106:1-24. 
[7] Ali, S.A., Hasan, K.A., Bin Asif, H. and Abbasi, A., 
“Environmental enterococci: Prevalence of virulence, antibiotic 
resistance and species distribution in poultry and its related 
environment in Karachi, Pakistan”, Lett. Appl. Microbiol. 2013, 
58:423-432. 
[8] Furlaneto-Maia, L., Real Rocha, K., Henrique, F.C., Giazzi, A. 
and Furlaneto Márcia, C., “Antimicrobial Resistance in 
Enterococcus sp isolated from soft cheese in Southern Brazil”, 
Adv. Microbiol. 2014, 4:175-181. 
[9] Hayes, J.R., English, L.L., Carter, P.J., Proescholdt, T., Lee, K.Y., 
Wagner, D.D. and White, D.G., “Prevalence and Antimicrobial 
Resistance of Enterococcus Species Isolated from Retail Meats”, 
Appl. Env. Microbiol. 2003, 69:7153-7160. 
[10] Jahan, M., Krause, D.O. and Holley, R.A., “Antimicrobial 
resistance of Enterococcus species from meat and fermented meat 
products isolated by a PCR-based rapid screening method”, Int. J. 
Food Microbiol. 2013, 163:89-95. 
[11] Klein, G., Pack, A. and Reuter, G., “Antibiotic resistance patterns 
of enterococci and occurrence of vancomycin-resistant enterococci 
in raw minced beef and pork in Germany”, Appl. Env. Microbiol. 
1998, 64:1825-1830. 
[12] Li, P., Wu, D., Liu, K., Suolang, S., He, T., Liu, X., Wu, C., Wang, 
Y. and Lin, D., “Investigation of Antimicrobial Resistance in 
Escherichia coli and Enterococci Isolated from Tibetan Pigs”, 
PLoS ONE. 2014, 9(4):e95623. 
[13] Moore, D.F., Guzman, J.A. and McGee, C., “Species distribution 
and antimicrobial resistance of enterococci isolated from surface 
and ocean water”, J. Appl. Microbiol. 2008, 105:1017-1025. 
[14] Turtura, G.C. and Lorenzelli, P., “Gram-positive cocci isolated 
from slaughtered poultry”, Microbiol. Res. 1994, 149:203-213. 
[15] Alfonsi, V., Camilli, R., Del Manso, M., D’Ambrosio, F., 
D’Ancona, F., Del Grosso, M., Giannitelli, S., Monaco, M., 
Sanchini, A., Sisto, A., Pantosti, A. e i referenti dei laboratori AR-
ISS, “AR-ISS: sorveglianza dell’antibiotico-resistenza in Italia. 
Rapporto del triennio 2006-2008. Rapporti Istisan 10/37”, Istituto 
Superiore di Sanità. [Online]. Available:  
http://old.iss.it/binary/publ/cont/10_37.pdf. [Accessed 25 
September 2018]. 
[16] Rathnayake, I.U., Hargreaves, M. and Huygens, F., “Antibiotic 
resistance and virulence traits in clinical and environmental 
Enterococcus faecalis and Enterococcus faecium isolates”, Syst. 
Appl. Microbiol. 2012, 35: 326-333. 
[17] Bonten, M.J, Willems, R. and Weinstein, R.A., “Vancomycin-
resistant enterococci: why are they here, and where do they come 
from?”, Lancet Infect. Dis. 2001, 1(5): 314-25. 
[18] Deshpande, L.M., Fritsche, T.R., Moet, G.J., Biedenbach, D.J. and 
Jones, R.N., “Antimicrobial resistance and molecular epidemiology 
of vancomycin-resistant enterococci from North America and 
Europe: a report from the SENTRY antimicrobial surveillance 
program”, Diagn. Micr. Infec. Dis. 2007, 58:163-70. 
[19] European Antimicrobial Resistance Surveillance System 
Management Team, Advisory Board and National Representatives, 
“EARSS Annual Report 2008. On-going surveillance of S. 
pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. 
pneumoniae, P. aeruginosa”, RIVM, Bilthoven, The Netherlands, 
2009. 
[20] Kayser, F.H, “Safety aspects of enterococci from the medical 
point of view”, Int. J. Food Microbiol. 2003, 88:255-262. 
[21] Poulsen, L.L., Bisgaard, M., Son, N.T., Trung, N.V., An, H.M. 
and Dalsgaard, A., “Enterococcus faecalis clones in poultry and in 
humans with urinary tract infections, Vietnam”, Emerg. Infect. Dis. 
2012, 18: 1096-1100. 
[22] Sapkota, A.R., Hulet, R.M., Zhang, G., McDermott, P., Kinney, 
E.L., Schwab Kellogg, J. and Joseph, S.W., “Lower prevalence of 
antibiotic resistant Enterococci on U.S. conventional poultry farms 
that transitioned to organic practices”, Environ. Health Perspect. 
2011, 119: 1622-1628. 
[23] Rizzotti, L., Simeoni, D., Cocconcelli, P., Gazzola, S., Dellaglio, F. 
and Torriani, S., “Contribution of enterococci to the spread of 
antibiotic resistance in the production chain of swine meat 
commodities”, J. Food Prot. 2005, 68:955-965. 
[24] Charpentier, E. and Courvalin, P., “Antibiotic resistance in 
Listeria spp.”, Antimicrob. Agents Ch. 1999, 43:2103-2108. 
[25] Courvalin, P., “Transfer of antibiotic resistance genes between 
gram-positive and gram-negative bacteria”, Antimicrob. Agents Ch. 
1994, 38:1447-1451. 
[26] Sparo, M., Urbizu, L., Solana, M.V., Pourcel, G., Delpech, G., 
Confalonieri, A., Ceci, M. and Sanchez Bruni, S.F., “High-level 
resistance to gentamycin: genetic transfer between Enterococcus 
faecalis isolated from food of animal origin and human 
microbiota”, Lett. Appl. Microbiol. 2011, 54: 119-125. 
[27] Walsh, D., Duffy, G., Sheridan, J.J., Blair, I.S. and McDowell, 
DA., “Antibiotic resistance among Listeria, including Listeria 
monocytogenes, in retail foods”, J. Appl. Microbiol. 2001, 90: 
517-522. 
[28] Shaked, H., Carmeli, Y., Schwartz, D. and Siegman-Igra, Y., 
“Enterococcal bacteraemia: epidemiological, microbiological, 
clinical and prognostic characteristics, and the impact of high level 
gentamicin resistance”, Scand. J. Inf. Dis. 2006, 38:995-1000. 
[29] Leclercq, R., Derlot, E., Duval, J. and Courvalin, P., “Plasmid 
Mediated Resistance to Vancomycin and Teicoplanin Resistance 
in Enterococcus faecium”, New Engl. J. Med. 1988, 319:157-161. 
[30] Shepard, B.D. and Gilmore, M.S., “Antibiotic-Resistant 
Enterococci: the mechanisms and dynamics of drug introduction 
and resistance”, Microbes Infect. 2002, 4.215-224. 
 
 Journal of Food and Nutrition Research 636 
[31] Eaton, T.J. and Gasson, M.J., “Molecular Screening of 
Enterococcus Virulence Determinants and Potential for Genetic 
Exchange between Food and Medical Isolates”, Appl. Environ. 
Microbiol. 2001, 67: 1628-1635. 
[32] Huys, G., D’Haene, K., Collard, J.C. and Swings, J., “Prevalence 
and Molecular Characterization of Tetracycline Resistance in 
Enterococcus Isolates from Food”, Appl. Env. Microbiol. 2004, 70: 
1555-1562. 
[33] Scheetz, M.H., Knechtel, S.A., Malczynski, M., Postelnick, M.J. 
and Qi, C., “Increasing incidence of linezolid-intermediate or - 
resistant, vancomycin-resistant Enterococcus faecium strains 
parallels increasing linezolid consumption”, Antimicrob. Agents 
Ch. 2008, 52:2256-2259. 
[34] Barbosa, J., Ferreira, V., Teixeira, P., “Antibiotic susceptibility of 
enterococci isolated from traditional fermented meat products”, 
Food Microbiol. 2009, 26:527-532.  
[35] Pesavento, G., Calonico, C., Ducci, B., Magnanini, A. and Lo 
Nostro, A., “Prevalence and Antibiotic Resistance of 
Enterococcus spp. isolated from retail cheese, ready-to-eat salads, 
ham, and raw meat”, Food Microbiol. 2014, 41:1-7. 
[36] Bauer, A.W., Kirby, W.M., Sherris, J.C., Turck, M., “Antibiotic 
susceptibility testing by a standardized single disk method”, Am. J. 
Clin. Pathol. 1966, 45:493-496. 
[37] The European Committee on Antimicrobial Susceptibility testing, 
EUCAST disk diffusion method for antimicrobial susceptibility 
testing. Version 6.0, 2017. [Online]. Available:  
http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/
Disk_test_documents/Version_5/Manual_v_6.0_EUCAST_Disk_
Test_final.pdf. [Accessed 25 September 2018]. 
[38] The European Committee on Antimicrobial Susceptibility testing, 
Breakpoint tables for interpretation of MICs and zone diameters. 
Version 7.1, 2017. [Online]. Available:  
http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/
Breakpoint_tables/v_7.1_Breakpoint_Tables.pdf. [Accessed 25 
September 2018]. 
[39] Clinical and Laboratory Standard Institute, Performance standards 
for antimicrobial susceptibility testing. 27th ed. CLSI supplement 
M100. Clinical and Laboratory Standards Institute, Wayne, PA, 2017. 
[40] Aarestrup, F.M., Hasman, H., Jensen, L.B., Moreno, M., Herrero, 
I.A., Domínguez, L., Finn, M. and Franklin, A., “Antimicrobial 
Resistance among Enterococci from Pigs in Three European 
Countries”, Appl. Environ. Microbiol. 2002, 68(8):4127-4129.  
[41] Kilonzo-Nthenge, A., Brown, A., Nahashon, S. N. and Long D., 
“Occurrence and Antimicrobial Resistance of Enterococci Isolated 
from Organic and Conventional Retail Chicken”, J. Food Prot. 
2015, 78(4):760-766. 
[42] Giraffa, G., Olivari, A.M and Neviani, E., “Isolation of 
vancomycin-resistant Enterococcus faecium from Italian cheeses”, 
Food Microbiol. 2000, 17:671-677. 
[43] European Food Safety Authority and European Centre for Disease 
Prevention and Control, EU Summary Report on antimicrobial 
resistance in zoonotic and indicator bacteria from humans, animals 
and food in 2013, EFSA J. 2015, 13(2):4036. 
[44] Obeng, A,S., Rickard, H., Ndi, O., Sexton, M. and Barton., M., 
“Prevalence of antimicrobial resistance in Enterococci and 
Escherichia coli in meat chicken flocks during a production cycle 
and egg layer pullet during rearing”, Int. J. Poultry Sci. 2014, 
13:489-503. 
[45] Amaechi, N. and Nwankwo, I.U., “Evaluation of Prevalence and 
Antimicrobial Resistance using Enterococci Isolates from Pigs and 
Poultry Birds in Abia State, Nigeria”, Int. J. Curr. Microbiol. App. 
Sci. 2015, 4(2):825-833. 
[46] Ayeni, F.A., Odumosu, B.T., Oluseyi, A.E. and Ruppitsch, W., 
“Identification and prevalence of tetracycline resistance in 
enterococci isolated from poultry in Ilishan, Ogun State, Nigeria”, 
J. Pharm. Bioall. Sci. 2016, 8:69-73. 
[47] European Food Safety Authority and European Centre for Disease 
Prevention and Control, “The European Union summary report on 
antimicrobial resistance in zoonotic and indicator bacteria from 
humans, animals and food in 2014”, EFSA J. 2016, 14(2):4380. 
[48] Angulo, F.J., Heuer, O.E., Hammerum, A.M., Collignon, P. and 
Wegener, H.C., “Human health hazard from antimicrobial-
resistant enterococci in animals and food”, Clin. Infect. Dis. 2006, 
43: 911-916. 
[49] Witte W., “Ecological impact of antibiotic use in animals on 
different complex microflora: environment”, Int. J. Antimicrob. Ag. 
2000, 14:321-325. 
[50] European Centre for Disease Prevention and Control, 
“Antimicrobial resistance surveillance in Europe 2014. Annual 
Report of the European Antimicrobial Resistance Surveillance 
Network (EARS-Net)”, European Centre for Disease Prevention 
and Control, Stockholm: ECDC, 2015. 
[51] O’Driscoll, T. and Crank, C.W., “Vancomycin-resistant 
enterococcal infections: epidemiology, clinical manifestations, and 
optimal management”, Infect. Drug Resist. 2015, 8:217-230. 
[52] Gaglio, R., Couto, N., Marques, C., de Fatima Silva Lopes, M., 
Moschetti, G., Pomba C. and Settanni, L., “Evaluation of 
virulence and antimicrobial resistance of enterococci isolated 
along the traditional cheese production chains”, Int. J. Food 
Microbiol. 2016, 236:107-114. 
[53] McGowan, L.L., Jackson, C.R., Barrett, J.B., Hiott, L.M. and 
Fedorka-Cray, P.J., “Prevalence and antimicrobial resistance of 
enterococci isolated from retail fruits, vegetables, and meats”, J. 
Food Prot. 2006, 69:2976-2982. 
[54] Garrido, A.M., Gálvez, A. and Pulido, R.P., “Antimicrobial 
Resistance in Enterococci”, J. Infect. Dis. Ther. 2014, 2:150. 
[55] Jahan, M., Zhanel, G.G., Sparling, R. and Holley, R.A., 
“Horizontal transfer of antibiotic resistance from Enterococcus 
faecium of fermented meat origin to clinical isolates of E. faecium 
and Enterococcus faecalis”, Int. J. Food Microbiol. 2015, 16:  
78-85. 
[56] Guerrero-Ramos, E., Cordero, J., Molina-Gonzalez, D., Poeta, P., 
Igrejas, G., Alonso-Calleja, C. and Capita, R., “Antimicrobial 
resistance and virulence genes in enterococci from wild game 
meat in Spain”, Food Microbiol. 2016, 53:156-164. 
[57] Citak, S., Yucel, N.L. and Mendi, A., “Antibiotic resistance of 
enterococcal isolates in raw milk”, J. Food Process. Pres. 2005, 
29: 183-195. 
[58] Regulation (EC) No 1831/2003 of the European Parliament and of 
the Council of 22 September 2003 on additives for use in animal 
nutrition, O. J. L. 268, 18.10.2003, 29-43. 
[59] Castanon, J.I.R., “History of the Use of Antibiotic as Growth 
Promoters in European Poultry Feeds”, Poultry Sci. 2007, 86(11): 
2466-2471. 
[60] Raeisi, J., Saifi, M., Pourshafie, M.R., Habibi, M., Mohajerani, 
H.R., Akbari, N. and Karam, M.R.A., “Rapid Identification of 
Vancomycin Resistant Enterococcus Faecalis Clinical Isolates 
using a Sugar Fermentation Method”, J Clin Diagn Res. 2017, 
11(3): DC14-DC17. 
[61] Novais, C., Freitas, A.R., Silveira, E., Antunes, P., Silva, R., 
Coque, T.M. and Peixe, L., “Spread of multidrug-resistant 
Enterococcus to animals and humans: an underestimated role for 
the pig farm environment”, J. Antimicrob. Chemother. 2013, 
68(12): 2746-54. 
[62] Hershberger, E., Oprea, S.F., Donabedian, S.M., Perri, M., 
Bozigar, P., Bartlett, P. and Zervos M.J., “Epidemiology of 
antimicrobial resistance in enterococci of animal origin”, J 
Antimicrob Chemother. 2005, 55(1): 127-30. 
[63] Seputiene, V., Bogdaite, A., Ruzauskas, M. and Suziedeliene, E., 
“Antibiotic resistance genes and virulence factors in Enterococcus 
faecium and Enterococcus faecalis from diseased farm animals: 
pigs, cattle and poultry”, Pol J Vet Sci. 2012, 15(3):431-8. 
[64] Kim, M.C., Cha, M.H., Ryu, J.G and Woo, G.J., “Characterization 
of Vancomycin-Resistant Enterococcus faecalis and Enterococcus 
faecium Isolated from Fresh Produces and Human Fecal Samples”, 
Foodborne Pathog Dis. 2017, 14(4): 195-201. 
[65] Berglund, B., “Environmental dissemination of antibiotic 
resistance genes and correlation to anthropogenic contamination 
with antibiotics”, Infect Ecol Epidemiol. 2015, 8(5):28564. 
[66] Bortolaia, V., Mander, M., Jensen, L.B., Olsen, J.E. and Guardabassi, 
L., “Persistence of vancomycin resistance in multiple clones of 
Enterococcus faecium isolated from Danish broilers 15 years after 
the ban of avoparcin”, Antimicrob Agents Chemother. 2015, 
59(5):2926-9. 
[67] European Medicines Agency, European Surveillance of Veterinary 
Antimicrobial Consumption (ESVAC), “Sales of veterinary 
antimicrobial agents in 30 European countries in 2015”, 2017. 
[Online]. Available:  
http://www.ema.europa.eu/docs/en_GB/document_library/Report/
2017/10/WC500236750.pdf [Accessed 25 September 2018]. 
[68] Donabedian, S.M., Thal, L.A., Hershberger, E., Perri, M.B., Chow, 
J.W., Bartlett, P., Jones, R., Joyce, K., Rossiter, S., Gay, K., 
Johnson, J., Mackinson, C., Debess, E., Madden, J., Angulo, F. 
and Zervos M.J., “Molecular characterization of gentamicin-
 
637 Journal of Food and Nutrition Research  
resistant Enterococci in the United States: evidence of spread from 
animals to humans through food”, J. Clin. Microbiol. 2003, 41: 
1109-1113. 
[69] Dubin, K. and Pamer, E.G., “Enterococci and Their Interactions 
with the Intestinal Microbiome”, Microbiol Spectr. 2014, 5(6). 
[70] European Centre for Disease Prevention and Control, 
“Antimicrobial resistance and causes of non-prudent use of 
antibiotics in human medicine in the EU”, European Centre for 
Disease Prevention and Control, Stockholm: ECDC, 2017. 
[71] Hidano, A., Yamamoto, T., Hayama, Y., Muroga, N., Kobayashi, 
S., Nishida, T. and Tsutsui, T., “Unraveling Antimicrobial 
Resistance Genes and Phenotype Patterns among Enterococcus 
faecalis Isolated from Retail Chicken Products in Japan”, PLoS 
ONE. 2015, 10(3): e0121189. 
[72] De Leener, E., Martel, A., Decostere, A. and Haesebrouck, F., 
“Distribution of the erm (B) gene, tetracycline resistance genes, 
and Tn1545-like transposons in macrolide- and lincosamide-
resistant enterococci from pigs and humans”, Microb Drug Resist. 
2004, 10(4): 341-345. 
 
 
